the goal of this observational study is to evaluate the role of VEXUS score and lung ultrasound to guide decongestive therapy in patients with cardiorenal syndr…

Egypt146 participantsStarted 2024-08-10

Treatment: frusemide

UnknownNot Applicable

NCT06065163

Ultrasound Guided Diuretic Therapy in Type 1 Cardiorenal Syndrome

A double-blind, randomized, controlled trial was conducted with the main objective of evaluating if patients with clinical assessment and VExUS reach decongesti…

Mexico80 participantsStarted 2022-09-01

Treatment: Diuretic de/escalation based on ultrasound findings (VExUS Score), Diuretic de/escalation based on clinical findings (CCS Score)

Cardiorenal Syndrome Type 1

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1

All recent trials (7 shown)

Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1

Ultrasound Guided Diuretic Therapy in Type 1 Cardiorenal Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1

All recent trials (7 shown)

Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1

Ultrasound Guided Diuretic Therapy in Type 1 Cardiorenal Syndrome

PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure

The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.

Bioimpedance and Hand-held Echocardiographay for Clinical Decision-making in Treatment of Cardio-renal Syndrome Type I

The Role of CVP and EF in Patients With Cardio-renal Syndromes